Life Technologies GlobalFiler Kit approved by FBI

Tuesday, 01 July, 2014

The United States Federal Bureau of Investigation (FBI) has granted approval of the Life Technologies GlobalFiler Kit, from Thermo Fisher Scientific, for forensic laboratories that generate DNA profiles and upload them to the Combined DNA Index System (CODIS) database. The agency’s decision was based on data submitted by the Alabama Department of Forensic Sciences (ADFS), which validated the solution that is designed to help solve serious crimes.

The GlobalFiler Kit and the previously approved GlobalFiler Express Kit are claimed to interrogate the broadest range of genetic data of any chemistry on the market, resulting in faster and more powerful comparisons of forensic samples to resolve crimes and help reduce the growing sample backlog waiting to be tested. Both contain all the genetic markers recommended for inclusion by the CODIS Core Loci Working Group, and 10 additional markers commonly used in Europe to reduce the risk of chance matches while enabling more effective data sharing among countries.

Managed by the National DNA Index System (NDIS), CODIS facilitates the electronic comparison and exchange of DNA profiles between participating local, county, state, and federal law-enforcement agencies and forensic laboratories. While approval of the GlobalFiler Kit primarily applies to the US forensic community, other countries follow the FBI’s guidance.

“As a trusted partner to forensic labs globally, we know that turn-around time, information recovery and cost efficiency are critically important to our customers,” said Nadia Altomare, vice president and general manager, Human Identification, Thermo Fisher Scientific. “That’s why the GlobalFiler chemistry has been designed to maximise profile information from the most challenging casework samples in a timely manner. Now with NDIS approval, the solution further expedites powerful data-matching capabilities to help solve crimes.”

Source

Related News

Blood-based biomarker can detect sleep deprivation

The biomarker detected whether individuals had been awake for 24 hours with a 99.2% probability...

Epigenetic signature helps to diagnose rare breast tumour

The current way of diagnosing phyllodes tumours is to analyse their cellular features under a...

New instrument measures cardiovascular disease biomarkers

CVD-21 enables a 'liquid cardiovascular biopsy' for quantification of multiple...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd